相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Mitochondrial alterations in Parkinson's disease: new clues
Miquel Vila et al.
JOURNAL OF NEUROCHEMISTRY (2008)
Cyclin-dependent kinase 5 supports neuronal survival through phosphorylation of Bcl-2
Zelda H. Cheung et al.
JOURNAL OF NEUROSCIENCE (2008)
Parkinson's disease
Bobby Thomas et al.
HUMAN MOLECULAR GENETICS (2007)
Turnover of mitochondrial steroidogenic acute regulatory (StAR) protein by lon protease: The unexpected effect of proteasome inhibitors
Zvi Granot et al.
MOLECULAR ENDOCRINOLOGY (2007)
Rapid down-regulation of Ret following exposure of dopaminergic neurons to neurotoxins
Yoko Hirata et al.
JOURNAL OF NEUROCHEMISTRY (2007)
p25/Cyclin-dependent kinase 5 promotes the progression of cell death in nucleus of endoplasmic reticulum-stressed neurons
Taro Saito et al.
JOURNAL OF NEUROCHEMISTRY (2007)
Cyclin-dependent kinase-5 prevents neuronal apoptosis through ERK-mediated upregulation of Bcl-2
C. X. Wang et al.
CELL DEATH AND DIFFERENTIATION (2006)
6-hydroxydopamine but not 1-methyl-4-phenylpyridinium abolishes α-synuclein anti-apoptotic phenotype by inhibiting its proteasomal degradation and by promoting its aggregation
CA da Costa et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2006)
Calpain-regulated p35/cdk5 plays a central role in dopaminergic neuron death through modulation of the transcription factor myocyte enhancer factor 2
PD Smith et al.
JOURNAL OF NEUROSCIENCE (2006)
Unique proteasome subunit Xrpn10c is a specific receptor for the antiapoptotic ubiquitin-like protein Scythe
Y Kikukawa et al.
FEBS JOURNAL (2005)
Mechanisms of protein degradation - An odyssey with ODC
C Kahana et al.
CELL CYCLE (2005)
Death-associated protein kinase as a sensor of mitochondrial membrane potential - Role of lysosome in mitochondrial toxin-induced cell death
SS Tiesong et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2005)
Differential roles of nuclear and cytoplasmic cyclin-dependent kinase 5 in apoptotic and excitotoxic neuronal death
MJ O'Hare et al.
JOURNAL OF NEUROSCIENCE (2005)
Control of cyclin-dependent kinase 5 (Cdk5) activity by glutamatergic regulation of p35 stability
FY Wei et al.
JOURNAL OF NEUROCHEMISTRY (2005)
20S proteasomal degradation of ornithine decarboxylase is regulated by NQ01
G Asher et al.
MOLECULAR CELL (2005)
Parkinson-like syndrome induced by continuous MPTP infusion:: Convergent roles of the ubiquitin-proteasome system and α-synuclein
F Fornai et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2005)
MPTP and SNpc DA neuronal vulnerability: Role of dopamine, superoxide and nitric oxide in neurotoxicity. Minireview.
V Jackson-Lewis et al.
NEUROTOXICITY RESEARCH (2005)
Mitochondrial assembly: protein import
DA Hood et al.
PROCEEDINGS OF THE NUTRITION SOCIETY (2004)
Proteasome mediates dopaminergic neuronal degeneration, and its inhibition causes α-synuclein inclusions
H Sawada et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2004)
Proteasome-dependent degradation of cyclin D1 in 1-methyl-4-phenylpyridinium ion (MPP+)-induced cell cycle arrest
J Bai et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2004)
Cdk5 deregulation in the pathogenesis of Alzheimer's disease
JC Cruz et al.
TRENDS IN MOLECULAR MEDICINE (2004)
Antizyme targets cyclin D1 for degradation - A novel mechanism for cell growth repression
RM Newman et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2004)
Cyclin-dependent kinase 5 is a mediator of dopaminergic neuron loss in a mouse model of Parkinson's disease
PD Smith et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2003)
Cyclin-dependent kinase-5 is involved in neuregulin-dependent activation of phosphatidylinositol 3-kinase and Akt activity mediating neuronal survival
BS Li et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2003)
Dysfunction of mitochondrial complex I and the proteasome:: interactions between two biochemical deficits in a cellular model of Parkinson's disease
GU Höglinger et al.
JOURNAL OF NEUROCHEMISTRY (2003)
Cdk5-mediated inhibition of the protective effects of transcription factor MEF2 in neurotoxicity-induced apoptosis
XM Gong et al.
NEURON (2003)
The regulation of cyclin-dependent kinase 5 activity through the metabolism of p35 or p39 Cdk5 activator
S Hisanaga et al.
NEUROSIGNALS (2003)
Mdm-2 and ubiquitin-independent p53 proteasomal degradation regulated by NQ01
G Asher et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2002)
Cyclin-dependent kinase 5 prevents neuronal apoptosis by negative regulation of c-Jun N-terminal kinase 3
BS Li et al.
EMBO JOURNAL (2002)
Expression of cyclin-dependent kinase 5 and its activator p35 in models of induced apoptotic death in neurons of the substantia nigra in vivo
M Neystat et al.
JOURNAL OF NEUROCHEMISTRY (2001)
Deregulation of Cdk5 in a mouse model of ALS:: Toxicity alleviated by perikaryal neurofilament inclusions
MD Nguyen et al.
NEURON (2001)
Oxidative stress inhibits the mitochondrial import of preproteins and leads to their degradation
G Wright et al.
EXPERIMENTAL CELL RESEARCH (2001)
Calpain-dependent proteolytic cleavage of the p35 cyclin-dependent kinase 5 activator to p25
G Kusakawa et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2000)
Neurotoxicity induces cleavage of p35 to p25 by calpain
MS Lee et al.
NATURE (2000)
分享论文
